Newsroom

JANUARY 12, 2022 by Conor Hale Roche has launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The cobas pulse will start shipping to select countries in Europe, carrying a CE mark, Roche said during the J.P. Morgan Healthcare Conference. The company said it plans to seek...

JANUARY 12, 2022 Amanda Petersen The partnership will leverage Glytec's insulin dosing support software to address challenges with hospital inpatient blood sugar management. Glytec, a Gold winner in the 2021 Medical Design Excellence Awards competition, has nabbed a rather big partnership with Roche that will ultimately benefit countless hospital patients and their clinicians. Through a digital...

February 2022 Glytec and Roche Diagnostics USA last month announced a digital health collaboration that combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander™, to address the pervasive challenges with inpatient blood sugar management at the hospital bedside. Glucommander will be the first software...

JANUARY 6, 2022 Karen Berger, PharmD Type 1 diabetes requires patients to have knowledge and skill to manage medication and potential complications. Type 1 diabetes (T1D) is caused when the immune system destroys the insulin-producing β cells of the pancreas. T1D accounts for up to 10% of all cases of diabetes. Because new-onset T1D can occur in any age group and people with the disease live for...

Leader in Endocrinology Research Implements eGlycemic Management System Across Hospitals, Dedicates Resources Towards Research and Development WALTHAM, Mass. (January 25, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around...

JANUARY 4, 2021 By: Sean Whooley Glytec announced today that its eGlycemic Management System received certified status for information security from HITRUST. Waltham, Massachusetts-based Glytec’s certification validates its platform’s ability to meet the highest standards for protecting sensitive data and information when working with its health system customers. According to a news release,...

As CMS Creates an Emphasis on Hyperglycemia and Hypoglycemia Rates in the Hospital, Partnership Aims to Transform the Standard of Care WALTHAM, MASS. (January 12, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a strategic partnership with Roche Diagnostics USA, a division of the world’s largest biotech company and a...

HITRUST CSF Certification validates Glytec is committed to meeting key regulations and protecting sensitive information. WALTHAM, MASS. (January 4, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced that Glytec’s eGlycemic Management System®, including Glucommander™, has achieved Certified status for information security by...

DECEMBER 1, 2021 By: Dr. Jordan Messler The focus on glycemic management as a key indicator of patient safety was announced as part of CMS’s annual adjustment to inpatient payment policies, which are accompanied by updated rules for its Inpatient Quality Reporting (IQR) program. This year, Centers for Medicare & Medicaid Services (CMS) has signaled a strong commitment to improving an...

NOVEMBER 22, 2021 Jordan Messler, MD, SFHM, FACP CMS' introduction of 3 new electronic clinical quality measures, 2 of which are focused on inpatient glycemic management, signal a strong commitment to shine a light on this often-overlooked area, according to the chief medical officer at Glytec. CMS recently completed its annual update of payment policies and rates for hospitals and long-term...